December 7, 2021 Comments Off on New patent for Azurity drug QBRELIS Posted in: Patent Added Annual Drug Patent Expirations for QBRELIS Qbrelis is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are seven patents protecting…
The post New patent for Azurity drug QBRELIS appeared first on DrugPaten…
December 7, 2021 Comments Off on New patent for Aprecia Pharms drug SPRITAM Posted in: Patent Added Annual Drug Patent Expirations for SPRITAM Spritam is a drug marketed by Aprecia Pharms and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Aprecia Pharms drug SPRITAM appeared first on DrugPate…
